jeudi 16 février 2017

Onco Actu du 16 février 2017

1. Biologie

What can cancer research learn from ‘the origin of life’? [The Institute of Cancer research]

3.1 Tabac

With colon cancer, smokers may be less likely to survive [Reuters]

3.2 Prévention - Obésité

Older women reduce their endometrial cancer risk with weight loss [Reuters]

4.11 Dép., diag. & prono. - Ovaire

Analyzing Copies of Genes Offers New Treatment Possibilities for Ovarian Cancer [UC San Diego]

4.9 Dép., diag. & prono. - Sein

More patients with early-stage breast cancer may be able to avoid chemotherapy in the future [MD Anderson]

Mammograms plus personalized treatment are the best options to fight breast cancer [STAT]

5. Traitements

First-Line Treatment of EGFR and ALK Wild-Type Advanced/Metastatic NSCLC: Refined Endpoints and Statistical Analysis Plan in the Phase III MYSTIC Study [ESMO]

Potential New Cancer Therapy Could Target Tumors Two Ways [NCI]

5.12.2 Immunothérapies - CAR-T

Number of CAR cell therapy trials worldwide [Cell Trials]

5.3 Traitements - FDA, EMA, NICE...

Europe ready to embrace first copies of biotech cancer drugs [Reuters]

5.4 Traitements - Economie

Venetoclax for treating chronic lymphocytic leukaemia [NICE]

NICE shoots down AbbVie's wannabe leukemia blockbuster Venclexta [FiercePharma]

NICE rejects AbbVie’s leukaemia drug [Pharmafile]

EU Maltese Presidency on Fairer Pricing for Cancer Drugs [ESMO]

5.5 ASCO

2017 Symposium Highlights Notable Research Advances in Genitourinary Cancers [ASCO]

6. Lutte contre les cancers

Henrietta Lacks’s family wants compensation for her cells [Washington Post]

6.7 DMP, Big Data & applis

We Order Anything From Anywhere In A Flash But Still Fill Out Paper Forms At The Doctor’s Office. Why? [Dr Len]

6.9 Controverses

Stop Freaking Out About CRISPR! (Except For One Thing) [Forbes]

The CRISPR patent decision: Your six takeaways [STAT]

Patent board tells CRISPR scientists to back off from a nasty fight over gene editing tech [EndPoints]

Round one of CRISPR patent legal battle goes to the Broad Institute [Science]

Patent Office Hands Win in CRISPR Battle to Broad Institute [MIT Technology Review]

Broad Institute wins bitter battle over CRISPR patents [Nature]

Harvard and M.I.T. Scientists Win Gene-Editing Patent Fight [NY Times]